Brief: Lundbeck, Takeda Modify Collaboration Agreement For Trintellix In U.S.

H Lundbeck A/S

31/07/2024 07:59

July 31 (Reuters) - H Lundbeck A/S  HLUNb.CO :
    * LUNDBECK AND TAKEDA MODIFY COLLABORATION AGREEMENT FOR
TRINTELLIX IN U.S.
    * H LUNDBECK A/S WILL CEASE ALL PROMOTIONAL EFFORTS FOR
TRINTELLIX
(VORTIOXETINE) IN U.S.
    * H LUNDBECK A/S WILL RECEIVE A FIXED, UNDISCLOSED ROYALTY
RATE
BASED ON NET SALES IN U.S. FOR 2025 AND 2026.
    * AGREEMENT IS EXPECTED TO HAVE ONLY A LIMITED IMPACT ON
REVENUE
AND ADJUSTED EBITDA


Further company coverage:  HLUNb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))